Clinical trial
Dose-Finding Study of E7070 in Combination With Irinotecan
NCT00060567 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00060567 |
|---|---|
| Title | Dose-Finding Study of E7070 in Combination With Irinotecan |
| Official title | Phase I Dose-Finding Study of E7070 in Combination With Irinotecan |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | E7070 + irinotecan combination, Irinotecan + E7070 combination |
| Enrollment | 88 |
| Start date | Mar 1, 2003 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | May 9, 2003 |
| Last update posted | Jun 18, 2023 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: